The coordinators of the European Parliament’s Special Committee on ‘Covid’ adopted, on Wednesday 11 January, a request from the Greens/EFA group to suspend the access of Albert Bourla, CEO of the pharmaceutical company Pfizer, to the European Parliament.
Mr Bourla had first cancelled his participation in a hearing with the committee, which wanted to question him in particular on the contracts for the supply of vaccines against Covid-19(see EUROPE B13039A13). Mr Bourla was replaced at...